Connect with us

Bioteknologia

Top 10 Biotech Big Data Companies

mm
Securities.io maintains rigorous editorial standards and may receive compensation from reviewed links. We are not a registered investment adviser and this is not investment advice. Please view our affiliate disclosure.

More Data For Better Medicine

The more we learn about biology, the more we realize all we do not know. It started with the genomic revolution and the first human genome sequenced in the early 2000s.

Genomics has now been joined by other datasets like transcriptomics, proteomics, metabolomics, microbiome, etc. forming a new “multiomics” science. We discussed in further detail this evolution in “Multiomics Are The Next Step In Biotechnology”.

These new tools have created a flood of data bringing detailed information about the inner activities of cells sometimes down to the atomic level. A key driver of this data growth has been the collapse of price of sequencing gene and other biological materials like proteins.

Source: ResearchGate

This has created enthusiasm about “Big Data” potential in biotech, mimicking the concept of big data from other, more IT-driven fields.

Already in 2018, the magazine Barron’s was asking “Will Big Data Lead to Big Biotech Returns?” and the industry started to ask “Implementing Large-Scale Data Processing and Analysis for Bioprocessing

Quite a few companies are well-positioned to benefit from the drive to create and analyze at-scale biological data.

AI Merging With Big Data?

A new development in the last few years has been the emergence of AI. While AI made its way into public consciousness mostly in 2023, with LLMs (Large Language Models) like ChatGPT, the biotech industry started to embrace AI many years before that.

Jonathan on entinen biokemian tutkija, joka on työskennellyt geneettisen analyysin ja kliinisten tutkimusten parissa. Hän on nyt osakkeiden analyytikko ja rahoituskirjailija, joka keskittyy innovaatioihin, markkinoiden sykleihin ja geopolitiikkaan julkaisussaan The Eurasian Century.

Advertiser Disclosure: Securities.io is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed. ESMA: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Investment advice disclaimer: The information contained on this website is provided for educational purposes, and does not constitute investment advice. Trading Risk Disclaimer: There is a very high degree of risk involved in trading securities. Trading in any type of financial product including forex, CFDs, stocks, and cryptocurrencies. This risk is higher with Cryptocurrencies due to markets being decentralized and non-regulated. You should be aware that you may lose a significant portion of your portfolio. Securities.io is not a registered broker, analyst, or investment advisor.